Technology | July 31, 2013

PTS Inc. Introduces CardioChek Plus Point-of-Care Plus Analyzer

The new system adds an electrochemical glucose test, Wi-Fi capabilities and additional ratios

July 31, 2013 — Polymer Technology Systems Inc. has introduced the CardioChek Plus analyzer. It is a combination reflectance lipid and electrochemical glucose analyzer that delivers rapid test results for lipids and glucose simultaneously. The system has Wi-Fi capabilities and can transmit patient results to data collection applications.  

It is the only point-of-care multi-analyte system of its kind that can provide a glucose result, a calculated low-density lipoprotein (LDL) measurement, a non-high-density lipoprotein (HDL) calculated measurement, an LDL/HDL ratio, and a total cholesterol (TC)/HDL ratio simultaneously with a simple fingerstick blood test sample while providing important total cholesterol, HDL cholesterol and triglycerides values at the same time.

The CardioChek Plus provides rapid on-site glucose plus lipid panel screening to help identify at-risk individuals. The capability to deliver both results in just two minutes enables healthcare professionals to improve their throughput, which is particularly important in today's health promotion/screening environment.  

The CardioChek Plus system builds upon the CardioChek PA platform by adding an electrochemical glucose test, Wi-Fi capabilities and additional ratios.  The electrochemical glucose capability provides a faster result than reflectance testing and enables total cholesterol, HDL cholesterol, triglycerides, calculated LDL cholesterol, total cholesterol/HDL ratio, LDL/HDL ratio, non-HDL and glucose results to be delivered simultaneously. 

The CardioChek Plus analyzer also performs all single and multiple analyte tests currently available for other CardioChek systems.  In addition, the device offers a larger, high-resolution screen and two-button operation, and there is no refrigeration required for test strips.

For more information: www.cardiochek.com

Related Content

FDA Clears Abbott's High Sensitivity Troponin-I Blood Test
Technology | Blood Testing | October 09, 2019
Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received clearance from...
Rapid Diagnosis Protocol for Chest Pain Does Not Improve Outcomes
News | Blood Testing | September 18, 2019
Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high-sensitivity cardiac troponin T...
Validation Studies Confirm High Accuracy of Novel HART AI-Driven Blood Tests
News | Blood Testing | March 19, 2019
Prevencio Inc. announced data confirming the high accuracy of its artificial intelligence (AI)-driven, multiple-protein...
CoaguChek XS PT Test Strips Recalled for Inaccurately Reporting High INR
News | Blood Testing | December 28, 2018
Terrific Care LLC. / Medex Supply Dist Inc. initiated a nationwide recall on Dec. 19 of Roche CoaguChek test strips, as...
Abbott Point-of-Care Blood Test Speeds Heart Attack Diagnosis
News | Blood Testing | October 26, 2018
For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether...
New Noninvasive Blood Glucose Test as Effective as Finger Prick

Image courtesy of University of Missouri School of Medicine

News | Blood Testing | October 24, 2018
For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related...
Abbott Receives CE Mark for High Sensitive Troponin-I Test
News | Blood Testing | October 16, 2018
October 16, 2018 — Abbott announced that its High Sensitive Troponin-I...
AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient
News | Blood Testing | September 04, 2018
Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral artery disease (PAD)...
More Sensitive Blood Test Diagnoses Heart Attacks Faster
News | Blood Testing | August 06, 2018
August 6, 2018 — A new test to assess a whether or not someone is having a...
Singulex cTnl Assay Can Identify Presence, Severity of CAD in Stable, Symptomatic Outpatients
News | Blood Testing | March 26, 2018
March 26, 2018 — Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singule